[HTML][HTML] The generation and application of patient-derived xenograft model for cancer research

J Jung, HS Seol, S Chang - Cancer research and treatment …, 2018 - synapse.koreamed.org
Establishing an appropriate preclinical model is crucial for translational cancer research.
The most common way that has been adopted by far is grafting cancer cell lines, derived …

[HTML][HTML] Nanocarriers for pancreatic cancer imaging, treatments, and immunotherapies

L Liu, PG Kshirsagar, SK Gautam, M Gulati, EI Wafa… - Theranostics, 2022 - ncbi.nlm.nih.gov
Pancreatic tumors are highly desmoplastic and immunosuppressive. Delivery and
distribution of drugs within pancreatic tumors are compromised due to intrinsic physical and …

Delineating copy number and clonal substructure in human tumors from single-cell transcriptomes

R Gao, S Bai, YC Henderson, Y Lin, A Schalck… - Nature …, 2021 - nature.com
Single-cell transcriptomic analysis is widely used to study human tumors. However, it
remains challenging to distinguish normal cell types in the tumor microenvironment from …

Studying cancer immunotherapy using patient-derived xenografts (PDXs) in humanized mice

Y Choi, S Lee, K Kim, SH Kim, YJ Chung… - Experimental & molecular …, 2018 - nature.com
Cancer immunotherapy is a promising way to eliminate tumor cells by using the patient's
own immune system. Selecting the appropriate animal models to develop or validate …

[HTML][HTML] Desmoplasia in pancreatic ductal adenocarcinoma: insight into pathological function and therapeutic potential

A Cannon, C Thompson, BR Hall, M Jain… - Genes & …, 2018 - ncbi.nlm.nih.gov
Extensive desmoplasia is a prominent feature of the pancreatic ductal adenocarcinoma
(PDAC) microenvironment. Initially, studies demonstrated that desmoplasia promotes …

Fibroblasts in pancreatic ductal adenocarcinoma: biological mechanisms and therapeutic targets

MC Whittle, SR Hingorani - Gastroenterology, 2019 - Elsevier
The desmoplastic reaction of pancreas cancer may begin as a wound healing response to
the nascent neoplasm, but it soon creates an insidious shelter that can sustain the growing …

Pancreatic cancer patient-derived organoids can predict response to neoadjuvant chemotherapy

L Demyan, AN Habowski, D Plenker, DA King… - Annals of …, 2022 - journals.lww.com
Objective: To evaluate if patient-derived organoids (PDOs) may predict response to
neoadjuvant (NAT) chemotherapy in patients with pancreatic adenocarcinoma. Background …

Tumor heterogeneity in pancreatic adenocarcinoma

J Cros, J Raffenne, A Couvelard, N Poté - Pathobiology, 2018 - karger.com
Pancreatic adenocarcinoma is one of the deadliest malignancies worldwide, mainly due to
frequent diagnosis at an advanced stage and its strong chemoresistance. Tumor …

A machine learning model for the prediction of survival and tumor subtype in pancreatic ductal adenocarcinoma from preoperative diffusion-weighted imaging

G Kaissis, S Ziegelmayer, F Lohöfer, H Algül… - European radiology …, 2019 - Springer
Background To develop a supervised machine learning (ML) algorithm predicting above-
versus below-median overall survival (OS) from diffusion-weighted imaging-derived …

A machine learning algorithm predicts molecular subtypes in pancreatic ductal adenocarcinoma with differential response to gemcitabine-based versus FOLFIRINOX …

G Kaissis, S Ziegelmayer, F Lohöfer, K Steiger, H Algül… - PloS one, 2019 - journals.plos.org
Purpose Development of a supervised machine-learning model capable of predicting
clinically relevant molecular subtypes of pancreatic ductal adenocarcinoma (PDAC) from …